TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 4 | 13 | 13 | 27 | 7 | 61 | 21 |
| P | %wins | 67 | 100 | 33 | 100 | 67 | 100 | 78 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/17 15:38 | 12/22/17 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spectrum Pharmaceuticals Inc | NV | T | P | 15 | 0.0100 | 0 | 1,519 | 15 | 11,548 | M | |||||||||||||||
11/1/16 18:51 | 10/28/16 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Spectrum Pharmaceuticals Inc | NV | T | P | 18 | 0.0100 | 0 | 1,789 | 22 | 10,029 | M | -19 | 9 | -7 | 18 | 29 | -10 | -1 | 1 | 1 | 1 | -1 | 0 | -18 | ||
8/16/16 19:16 | 7/14/16 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Spectrum Pharmaceuticals Inc | NV | T | P.m | 11 | 0.0100 | 0 | 1,145 | 16 | 8,240 | M | -45 | -33 | 17 | -14 | -6 | -13 | -6 | -8 | -1 | 2 | -9 | 25 | 16 | ||
3/11/16 19:43 | 2/22/16 | CASI | Casi Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Spectrum Pharmaceuticals Inc | NV | T | P | 17 | 0.0100 | 0 | 1,689 | 31 | 7,094 | M | -48 | -38 | -22 | -6 | -16 | 7 | 6 | -4 | 11 | 37 | 48 | 56 | 24 | 61 | |
9/6/12 17:15 | 9/5/12 | ALTH | Allos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Spectrum Pharmaceuticals Inc | NV | T | P | 238,156 | 1.82 | 0 | 130,855 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |